Mathew Blurton-Jones

27PUBLICATIONS
181CO-AUTHORS
Medical biochemistry - lipidsMedical infection agents (incl. prions)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 29, 2026
Reduced LACTB expression in myeloid cells is associated with elevated succinylcarnitine and reduced Alzheimer's disease risk.

|Dec 03, 2025
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer's disease.

Tanya N Weerakkody, Hanna Sabelström, Shan V Andrews

|Nov 24, 2025
Brain wide engraftment of human monocytes induces neurodegeneration and cognitive dysfunction.

Mathew Blurton-Jones, Hayk Davtyan, Jean Paul Chadarevian

|Nov 21, 2025
Human microglia differentially respond to β-amyloid, tau, and combined Alzheimer's disease pathologies in vivo.

Morgan A Coburn, Ghazaleh Eskandari-Sedighi, Jonathan Hasselmann

|Oct 15, 2025
Microglia-specific regulation of lipid metabolism in Alzheimer's disease revealed by microglial depletion in 5xFAD Mice.

Ziying Xu, Sepideh Kiani Shabestari, Savannah Barannikov

|Apr 09, 2025
Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease.

Kimitoshi Kimura, Ayshwarya Subramanian, Zhuoran Yin

Pageof 5

Frequent Collaborators

14 joint publications

Hayk Davtyan

5 joint publications

Jonathan Hasselmann

4 joint publications

Jean Paul Chadarevian

4 joint publications

Amanda McQuade